These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
816 related items for PubMed ID: 23841532
1. A return to normal erectile function with tadalafil once daily after an incomplete response to as-needed PDE5 inhibitor therapy. Kim ED, Seftel AD, Goldfischer ER, Ni X, Burns PR. J Sex Med; 2014 Mar; 11(3):820-30. PubMed ID: 23841532 [Abstract] [Full Text] [Related]
2. Comparative efficacy of tadalafil once daily in men with erectile dysfunction who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or vardenafil. Kim E, Seftel A, Goldfischer E, Baygani S, Burns P. Curr Med Res Opin; 2015 Feb; 31(2):379-89. PubMed ID: 25455432 [Abstract] [Full Text] [Related]
3. Treatment satisfaction of men and partners following switch from on-demand phosphodiesterase type 5 inhibitor therapy to tadalafil 5 mg once daily. Burns PR, Rosen RC, Dunn M, Baygani SK, Perelman MA. J Sex Med; 2015 Mar; 12(3):720-7. PubMed ID: 25615445 [Abstract] [Full Text] [Related]
4. Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction. Buvat J, Büttner H, Hatzimouratidis K, Vendeira PA, Moncada I, Boehmer M, Henneges C, Boess FG. J Sex Med; 2013 Jun; 10(6):1592-602. PubMed ID: 23551622 [Abstract] [Full Text] [Related]
5. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Yuan J, Zhang R, Yang Z, Lee J, Liu Y, Tian J, Qin X, Ren Z, Ding H, Chen Q, Mao C, Tang J. Eur Urol; 2013 May; 63(5):902-12. PubMed ID: 23395275 [Abstract] [Full Text] [Related]
6. A randomized open-label trial with a crossover comparison of sexual self-confidence and other treatment outcomes following tadalafil once a day vs. tadalafil or sildenafil on-demand in men with erectile dysfunction. Rubio-Aurioles E, Porst H, Kim ED, Montorsi F, Hackett G, Morales AM, Stuckey B, Būttner H, West TM, Huynh NN, Lenero E, Burns P, Kopernicky V. J Sex Med; 2012 May; 9(5):1418-29. PubMed ID: 22429760 [Abstract] [Full Text] [Related]
7. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT). Montorsi F, Brock G, Stolzenburg JU, Mulhall J, Moncada I, Patel HR, Chevallier D, Krajka K, Henneges C, Dickson R, Büttner H. Eur Urol; 2014 Mar; 65(3):587-96. PubMed ID: 24169081 [Abstract] [Full Text] [Related]
8. Impact of low testosterone on response to treatment with tadalafil 5 mg once daily for erectile dysfunction. Goldfischer ER, Kim ED, Seftel AD, Baygani SK, Burns PR. Urology; 2014 Jun; 83(6):1326-33. PubMed ID: 24726311 [Abstract] [Full Text] [Related]
10. Effects of Tadalafil Once-Daily or On-Demand vs Placebo on Return to Baseline Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy--Results from a Randomized Controlled Trial (REACTT). Mulhall JP, Brock G, Oelke M, Fode M, Probst KA, Henneges C, d'Anzeo G, Rossi A, Büttner H. J Sex Med; 2016 Apr; 13(4):679-83. PubMed ID: 27045264 [Abstract] [Full Text] [Related]
12. Durability of response following cessation of tadalafil taken once daily as treatment for erectile dysfunction. Porst H, Glina S, Ralph D, Zeigler H, Wong DG, Woodward B. J Sex Med; 2010 Oct; 7(10):3487-94. PubMed ID: 20584129 [Abstract] [Full Text] [Related]